Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Gonadorelin

GnRH, Luteinizing Hormone-Releasing Hormone, LHRH, Factrel

Quick Stats
Studies 192
Trials 100
2025 pubmed

Central SELENOT deficiency impairs gonadotrope axis function, sexual behavior and fertility in male and female mice.

Mallouki. Ben Yamine BY; Boukhzar. Loubna L; Dumont. Ludovic L; Abgrall. Azénor A; Gras. Marjorie M; Prieur. Agathe A; Alexandre. David D; Godefroy. David D; Tillet. Yves Y; Grumolato. Luca L; Rives. Nathalie N; Chigr. Fatiha F; Anouar. Youssef Y

Abstract

Reproductive disorders can result from a defective action of the neuropeptide gonadotropin-releasing hormone (GnRH), the master regulator of reproduction. We have previously shown that SELENOT, a newly-described thioredoxin-like selenoprotein highly expressed in endocrine and neuroendocrine cells, plays a role in hormone secretion and neuroprotection. However, whether SELENOT is involved in neuro-endocrine regulations in vivo is totally unknown. We found that SELENOT deficiency in the brain impaired sexual behavior, leading to a decline in fertility in both male and female mice. Biochemical and histological analyses of the gonadotrope axis of these mice revealed a higher expression of GnRH, which is associated with circulating luteinizing hormone (LH) excess, and elevated steroid hormones in males and a polycystic ovary syndrome (PCOS)-like phenotype in females. In addition, SELENOT deficiency impaired LH pulse secretion in both male and female mice. These alterations are reverted after administration of a GnRH antagonist. Together, our data demonstrate for the first time the role of a selenoprotein in the central control of sexual behavior and reproduction, and identify a new redox effector of GnRH neuron activity impacting both male and female reproductive function.

Study Information

Provider

pubmed

Year

2025

Date

2025-11-06T00:00:00.000Z

DOI

10.1172/jci.insight.189775